Elaborate evaluation of serum and tissue oxidized LDL level with darapladib therapy: A feasible diagnostic marker for early atherogenesis
Sign Up to like & getrecommendations! Published in 2017 at "Asian pacific Journal of Tropical Biomedicine"
DOI: 10.1016/j.apjtb.2016.11.014
Abstract: Objective To compare oxidized low density lipoprotein (oxLDL) levels in serum and vascular wall of Sprague-Dawley rats, identify their patterns in 8 weeks and 16 weeks of dyslipidemia induced by high fat diet, compare foam… read more here.
Keywords: oxidized ldl; tissue oxidized; ldl level; serum tissue ... See more keywords
What is the potential cardiovascular risk reduction associated with achieving LDL-C levels recommended in the ESC/EAS guidelines for very high-risk patients? Data from 18 European countries
Sign Up to like & getrecommendations! Published in 2020 at "European Heart Journal"
DOI: 10.1093/ehjci/ehaa946.3003
Abstract: For patients at very-high risk of cardiovascular (CV) events, the 2016 ESC/EAS dyslipidaemia guidelines recommended lipid-lowering therapy (LLT) to achieve an LDL-C level below 70 mg/dL. This was lowered to an LDL-C level below 55… read more here.
Keywords: reduction; risk; ldl level; ldl ... See more keywords
48-week of statin therapy for T2DM patients with LEAD: comparison of the effects of pitavastatin and atorvastatin on lower femoral total plaque areas.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of diabetes investigation"
DOI: 10.1111/jdi.13472
Abstract: AIMS Type 2 diabetes mellitus (T2DM) is correlated with systemic atherosclerosis. Statin therapies have been proved to reduce low-density lipoprotein cholesterol (LDL-C) level, protecting T2DM patients from cardiovascular events. Recently, more interest has been focused… read more here.
Keywords: t2dm; t2dm patients; effects pitavastatin; ldl level ... See more keywords
Low LDL-C level and intracranial haemorrhage risk after ischaemic stroke: a prospective cohort study
Sign Up to like & getrecommendations! Published in 2022 at "Stroke and Vascular Neurology"
DOI: 10.1136/svn-2022-001612
Abstract: Background and purpose The Treat Stroke to Target trial has confirmed the benefit of targeting low-density lipoprotein cholesterol (LDL-C) of read more here.
Keywords: mmol; ldl level; intracranial haemorrhage; risk ... See more keywords
The Role of Fasting LDL-C Levels in Their Non-fasting Reduction in Patients With Coronary Heart Disease
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2021.686234
Abstract: The level of low-density lipoprotein cholesterol (LDL-C) decreases to a certain extent after daily meals; however, the influencing factor of this phenomenon has not been fully elucidated. This study included 447 patients with coronary heart… read more here.
Keywords: reduction; fasting ldl; ldl level; level ... See more keywords
Non-fasting Changes in Blood Lipids After Three Daily Meals Within a Day in Chinese Inpatients With Cardiovascular Diseases
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2022.799300
Abstract: Background Non-fasting (i.e., postprandial) lipid detection is recommended in clinical practice. However, the change in blood lipids in Chinese patients with cardiovascular diseases after three daily meals has never been reported yet. Methods Serum levels… read more here.
Keywords: daily meals; blood lipids; three daily; level ... See more keywords